PrOspEctive Metastases Imaging (POEM)
NCT07781306 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2026-08-24
Summary
This is a non-interventional, observational study with an optional interventional biobanking activity. Liver metastases of patients undergoing partial hepatectomy will be sampled completely while respecting the orientation used for medical imaging, in order to correlate the histopathological growth patterns in a 3D-map with the imaging characteristics. The full pathological sampling will only use remnant tissue.
Conditions
Sponsors & Collaborators
-
Cancer Research Antwerp
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-09-08
- Primary Completion
- 2027-12-31
- Completion
- 2028-05-31
Countries
- Belgium
Study Locations
More Related Trials
-
Positron Emission Tomography - Computed Tomography (PET-CT) Cetuximab Project
NCT00828620 ·Status: TERMINATED
-
Diffusion-Weighted MRI for Liver Metastasis
NCT02781935 ·Status: COMPLETED
-
Diagnostic Performance Of 4D Dynamic LAFOV FDG-PET Acquisition for Differentiation of Residual Disease and Post-radiation Inflammation in Head Neck SCC Treated by Radiotherapy.
NCT07417605 ·Status: RECRUITING
-
Evaluation of Metabolic Activity of Liver Metastases by FDG-PET Scanning
NCT00184782 ·Status: UNKNOWN ·Phase: NA
-
PRetreatment MRI for OCcult Liver Metastasis Assessment In Pancreatic Ductal adenocarcinoMa
NCT07252076 ·Status: RECRUITING
-
Magnetic Resonance Imaging (MRI) Using Liverspecific Oral Contrast Agent in Metastatic Colorectal Cancer Patients
NCT00718055 ·Status: WITHDRAWN
-
Porto-Venous Radiomics in Pancreatic Cancer
NCT05700110 ·Status: UNKNOWN
-
Contribution of 18FDG PET-Scan in Tumour Volume Determination in Patients Operated of Breast Cancer
NCT01621529 ·Status: COMPLETED
-
Correlating the Tumoral Metabolic Progression Index to Patient's Outcome in Advanced Colorectal Cancer
NCT01591590 ·Status: COMPLETED ·Phase: NA
-
Magnetic Resonance Imaging of the Whole Body, Including Diffusion, in the Medical Evaluation of Breast Cancers at High Risk for Metastasis and the Follow-up of Metastatic Cancers
NCT02966574 ·Status: UNKNOWN ·Phase: NA
-
Imaging Multiparametric/Multimodality for Lungcancer
NCT02977663 ·Status: UNKNOWN ·Phase: NA
-
Evaluating the roLe of Multiplexed PET Imaging in the Detection and Staging of hepatocellulaR Carcinoma and gAstro-entero-pancreatic Tumors
NCT07178587 ·Status: RECRUITING ·Phase: NA
-
68Ga-PSMA-617 PET/CT for PSMA-expressing Tumor: a Pragmatic Study
NCT05228106 ·Status: RECRUITING
-
Localising Occult Prostate Cancer Metastases With Advanced Imaging TEchniques
NCT02935816 ·Status: UNKNOWN
-
The Value of Diffusion-weighted Imaging in Evaluating the Early Efficacy of Liver Metastasis in Colorectal Cancer
NCT03088163 ·Status: UNKNOWN ·Phase: NA
-
Multi-modality Imaging in the Prediction of Response to Systemic Treatment in Colorectal Cancer
NCT01292681 ·Status: UNKNOWN ·Phase: NA
-
Role PET Imaging in Response Assessment for Hepatocellular Carcinoma (HCC)
NCT01116804 ·Status: COMPLETED ·Phase: PHASE1
-
Imaging Study in Metastatic UC, HR+ and HER2- Breast Cancer, TNBC, and NSCLC
NCT07671092 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Intraoperative Imaging With ICG Registry
NCT02640170 ·Status: COMPLETED
-
Utility of PET In the Pre-Operative Assessment of Patients With Hepatic Colorectal Metastases
NCT00588549 ·Status: COMPLETED
-
Imaging of ER Density to Guide and Improve Tailored Therapy for Acquired Anti-hormonal Resistant Breast Cancer
NCT01088477 ·Status: COMPLETED
-
Identification of Hepatic Lesions
NCT00307866 ·Status: COMPLETED ·Phase: PHASE3
-
Diffusion MRI for Pancreatic Adenocarcinoma
NCT02896946 ·Status: COMPLETED ·Phase: NA
-
Early Metabolic Response in Locally Advanced Esophageal Cancer Undergoing Induction Chemoradiotherapy
NCT01269970 ·Status: COMPLETED
-
Specimen PET-CT Imaging for Intraoperative Margin Assessment in Breast Cancer
NCT04999917 ·Status: COMPLETED ·Phase: NA